GRANT Tuesday, September 30, 2014- 11:45 BrightFocus Foundation Variable October 14, 2014 BrightFocus Foundation Alzheimer's Disease Research Award ...
THERAPEUTICS AstraZeneca Immunotherapy (passive) Amyloid-Related In February 2014, AstraZeneca started a multicenter phase 1 trial in the U.S., which is to enroll 242 people with mild to moderate Alzheimer's disease. The study will evaluate single and multiple ...
THERAPEUTICS Eli Lilly & Co. N3pG-amyloid-beta Monoclonal Antibody Immunotherapy (passive) Amyloid-Related In May 2013, Lilly started a phase 1 study in 100 people on the spectrum of mild cognitive impairment due to Alzheimer's disease to mild Alzheimer' ...
PrivateSan Francisco, United States
St Petersburg, United States
No filters selected